Literature DB >> 23970753

Mycobacterium arupense infection in HIV-infected patients from Iran.

P Heidarieh1, A Hashemi-Shahraki, A D Khosravi, S Zaker-Boustanabad, H Shojaei, M M Feizabadi.   

Abstract

Here we report two cases of infection caused by Mycobacterium arupense in HIV-infected patients who had received Mycobacterium avium complex medication after primary treatment with antituberculous drugs. The causative agents were isolated from the respiratory and blood specimens of the patients. The identification was based on conventional and molecular tests. Our study provides further evidence on the role of this microorganism in clinical cases.

Entities:  

Keywords:  AIDS; HIV; Iran; Mycobacterium arupense; atypical mycobacteria; non-tuberculous mycobacteria; treatment

Mesh：

Substances：

Year:  2013        PMID： 23970753     DOI： 10.1177/0956462412472818

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN： 0956-4624            Impact factor:   1.359


  8 in total

Review 1.  Mycobacterium arupense flexor tenosynovitis: case report and review of antimicrobial susceptibility profiles for 40 clinical isolates.

Authors:  Elena Beam; Shawn Vasoo; Patricia J Simner; Marco Rizzo; Erin L Mason; Randall C Walker; Sharon M Deml; Barbara A Brown-Elliott; Richard J Wallace; Nancy L Wengenack; Irene G Sia
Journal:  J Clin Microbiol       Date:  2014-04-30       Impact factor: 5.948

Review 2.  Nontuberculous Mycobacteria Isolation from Clinical and Environmental Samples in Iran: Twenty Years of Surveillance.

Authors:  Ali Akbar Velayati; Parissa Farnia; Mohadese Mozafari; Mehdi Mirsaeidi
Journal:  Biomed Res Int       Date:  2015-05-28       Impact factor: 3.411

3.  First Korean Case of Mycobacterium arupense tenosynovitis.

Authors:  Seung Jun Lee; Sung Kuk Hong; Sung Sup Park; Eui-Chong Kim
Journal:  Ann Lab Med       Date:  2014-06-19       Impact factor: 3.464

4.  Mycobacterium arupense as an Emerging Cause of Tenosynovitis.

Authors:  Fiorella Krapp Lopez; Madeline Miley; Babafemi Taiwo
Journal:  Emerg Infect Dis       Date:  2016-03       Impact factor: 6.883

5.  Mycobacterium arupense in Cancer Patients: An Emerging Infection or a Commensal Organism.

Authors:  Zainab Al Hamal; Mary Jordan; Ray Y Hachem; Hussain M Alawami; Abdussalam M Alburki; Ammar Yousif; Poonam Deshmukh; Ying Jiang; Ann-Marie Chaftari; Issam I Raad
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

6.  Clinical and Laboratory Characteristics of Patients with Nontuberculous Mycobacterium Bloodstream Infection in a Tertiary Referral Hospital in Beijing, China.

Authors:  Sai-Nan Bian; Li-Fan Zhang; Yue-Qiu Zhang; Qi-Wen Yang; Peng Wang; Ying-Chun Xu; Xiao-Chun Shi; Xiao-Qing Liu
Journal:  Chin Med J (Engl)       Date:  2016-09-20       Impact factor: 2.628

Review 7.  Mycobacterium arupense: A review article on an emerging potential pathogen in the Mycobacterium terrae complex.

Authors:  Naief N Abudaff; Elena Beam
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2017-11-22

8.  Isolation of Mycobacterium arupense from pleural effusion: culprit or not?

Authors:  Xian Zhou; Qiaoling Ruan; Weimin Jiang; Xinyu Wang; Yuan Jiang; Shenglei Yu; Yu Xu; Jing Li; Yangyi Zhang; Wenhong Zhang; Yuekai Hu
Journal:  BMC Infect Dis       Date:  2018-05-15       Impact factor: 3.090
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.